Pictet Asset Management Holding Sa Gilead Sciences, Inc. Transaction History
Pictet Asset Management Holding Sa
- $93.5 Billion
- Q2 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 2,637,119 shares of GILD stock, worth $312 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
2,637,119
Previous 3,177,669
17.01%
Holding current value
$312 Million
Previous $356 Million
17.88%
% of portfolio
0.31%
Previous 0.41%
Shares
8 transactions
Others Institutions Holding GILD
# of Institutions
2,330Shares Held
1.03BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$14.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.1 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$7.01 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.49 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.45 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $148B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...